Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Nephrology · Renovascular Hypertension

The Diagnostic Journey: Confirming Renovascular Hypertension

At a Glance

Doctors diagnose renovascular hypertension by monitoring for creatinine spikes after starting certain blood pressure medications, followed by imaging. Doppler ultrasound is a safe first step, while catheter angiography is the gold standard that allows for immediate treatment.

Diagnosing renovascular hypertension (RVH) is rarely a single step. Instead, it is a journey that typically begins with a clinical suspicion and moves through various types of imaging to confirm the exact location and severity of the narrowing in your kidney arteries [1].

The “Creatinine Clue”: A Diagnostic Red Flag

One of the most important clues doesn’t come from a picture, but from a blood test. If your doctor starts you on a common blood pressure medication like an ACE inhibitor (e.g., Lisinopril) or an ARB (e.g., Losartan), they will monitor your creatinine levels closely a few days after starting [2]. This is done proactively to ensure the medication is safe for you.

In a kidney with a severely narrowed artery, the body uses a hormone called Angiotensin II to “clamp down” on the exit of the kidney’s filter, maintaining enough internal pressure to function [3]. These medications remove that “clamp.” If the narrowing is severe in both kidneys—or in your only working kidney—your kidney function will suddenly drop, causing a sharp spike in creatinine [4]. This reaction is a major diagnostic signal that significant renal artery stenosis is present, which is why doctors check your blood work shortly after starting these prescriptions [3].

Non-Invasive Imaging: Seeing the Narrowing

Your doctor will likely start with one of these three tests to “see” your arteries without the need for surgery:

  • Doppler Ultrasound: This uses sound waves to measure the speed of blood flow [5].
    • Pros: It is safe, inexpensive, and uses no radiation or contrast dye [5].
    • Cons: It is highly dependent on the skill of the technician and can be difficult to perform if a patient is overweight or has excess gas in the intestines [6].
  • CT Angiography (CTA): This uses a CT scanner to create highly detailed 3D images of the arteries [7].
    • Pros: It is very accurate and fast [7].
    • Cons: It requires a small amount of radiation and an iodinated contrast dye, which may not be suitable for people with existing kidney damage [8].
  • MR Angiography (MRA): This uses magnetic fields and radio waves to image the blood vessels [9].
    • Pros: It provides excellent detail, and certain types can be done without any contrast dye at all [10].
    • Cons: It is more expensive and time-consuming than a CT scan [10]. If contrast (gadolinium) is used, it carries a rare risk of a severe condition called Nephrogenic Systemic Fibrosis in patients with advanced kidney disease.

The Gold Standard: Catheter Angiography

Catheter angiography (also called DSA) is considered the “gold standard” because it provides the most precise and definitive view of the blood flow [11].

During this procedure, a doctor inserts a thin tube (catheter) through an artery in your groin or arm and guides it to the kidney arteries, where a special dye is injected [12]. Because it is invasive and carries small risks, it is usually reserved for two scenarios:

  1. When non-invasive tests (like ultrasound or CT) don’t provide a clear answer but suspicion remains high [13].
  2. When a doctor plans to fix the narrowing during the same procedure using angioplasty or a stent [1].

Common questions in this guide

Why did my creatinine spike after starting a new blood pressure medication?
A sudden spike in creatinine after starting an ACE inhibitor or ARB can be a major warning sign. These medications remove the pressure your kidneys use to function through a narrow artery, causing kidney function to drop and creatinine to rise.
What is the safest imaging test for my kidney arteries if I already have kidney damage?
Doppler ultrasound is often the safest starting point because it uses sound waves and does not require radiation or contrast dye. If a clearer picture is needed, certain types of MRI can be performed without dye, which helps protect your remaining kidney function.
Will I need an invasive procedure to diagnose my narrowed kidney arteries?
Not necessarily. Most diagnoses start with non-invasive tests like an ultrasound, CT scan, or MRI. An invasive procedure called catheter angiography is usually only recommended if the non-invasive tests are unclear or if your doctor plans to place a stent at the same time.
What are the risks of using contrast dye for kidney imaging?
Contrast dye used in CT scans can sometimes worsen existing kidney damage. Additionally, the gadolinium dye used in some MRIs carries a rare risk of causing nephrogenic systemic fibrosis in patients who already have advanced kidney disease.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current kidney function, which imaging test—Doppler, CT, or MRI—is the safest and most accurate for me?
  2. 2.If my Doppler ultrasound was inconclusive, do we need to proceed to a CTA or MRA before considering an invasive procedure?
  3. 3.Is my recent rise in creatinine a normal side effect of my new medication, or does it suggest my renal artery narrowing is severe?
  4. 4.If we decide to do a catheter angiography, will you be prepared to perform an angioplasty or stenting during the same procedure?
  5. 5.What are the risks of using contrast dye for a CTA or MRA given my specific kidney health?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Diagnosis and Treatment of Renal Artery Stenosis in China in the Era of Donation After Cardiac Death.

    Wang Q, Li X, Liu Z, et al.

    Annals of transplantation 2020; (25()):e918076 doi:10.12659/AOT.918076.

    PMID: 32015300
  2. 2

    Incidence of hyperkalaemia and major creatinine elevation after renin-angiotensin system inhibitor initiation in a Singapore primary care cohort.

    Lim MW, Szücs A, Ong D, Van Der Lubbe SCC

    BMC primary care 2026; (27(1)).

    PMID: 41629800
  3. 3

    Severe acute kidney injury in a patient with renal artery stenosis of a single-functioning kidney: A case report of rapid normalisation of the renal function after percutaneous transluminal angioplasty with stent placement.

    Seydoux C, Hemett OM, Périard D, Descombes E

    SAGE open medical case reports 2023; (11()):2050313X231209639 doi:10.1177/2050313X231209639.

    PMID: 37941982
  4. 4

    Clinical Utility of Duplex Ultrasonography in the Recognition of Transplant Renal Artery Stenosis: A Single Center Experience.

    Mirza A, Baig U, Khan M, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(14)) doi:10.3390/diagnostics15141766.

    PMID: 40722517
  5. 5

    Imaging strategies for safety surveillance after renal artery denervation.

    Cohen DL, Weinberg I, Uretsky S, et al.

    Clinical research in cardiology : official journal of the German Cardiac Society 2021; (110(5)):609-619 doi:10.1007/s00392-021-01819-w.

    PMID: 33646357
  6. 6

    Case Report: Renal artery stenosis in children: ultrasound as a decisive diagnostic and therapy-accompanying technique!

    Brasseler M, Finkelberg I, Müntjes C, Cetiner M

    Frontiers in pediatrics 2023; (11()):1251757 doi:10.3389/fped.2023.1251757.

    PMID: 38078312
  7. 7

    Validation of computed tomography angiography as a complementary test in the assessment of renal artery stenosis: a comparison with digital subtraction angiography.

    Fleury AS, Durand RE, Cahill AM, et al.

    Pediatric radiology 2021; (51(13)):2507-2520 doi:10.1007/s00247-021-05145-1.

    PMID: 34374838
  8. 8

    Evaluation of the Renal Arteries of 2,144 Living Kidney Donors Using Computed Tomography Angiography and Comparison with Intraoperative Findings.

    Sarier M, Callioglu M, Yuksel Y, et al.

    Urologia internationalis 2020; (104(7-8)):637-640 doi:10.1159/000507796.

    PMID: 32408307
  9. 9

    Non-contrast MR angiography versus contrast enhanced MR angiography for detection of renal artery stenosis: a comparative analysis in 400 renal arteries.

    Lal H, Singh RKR, Yadav P, et al.

    Abdominal radiology (New York) 2021; (46(5)):2064-2071 doi:10.1007/s00261-020-02836-5.

    PMID: 33136181
  10. 10

    Non-contrast-enhanced MRA of renal artery stenosis: validation against DSA in a porcine model.

    Bley TA, François CJ, Schiebler ML, et al.

    European radiology 2016; (26(2)):547-55 doi:10.1007/s00330-015-3833-x.

    PMID: 26017736
  11. 11

    A simple, refined approach to diagnosing renovascular hypertension in children: A 10-year study.

    Saida K, Kamei K, Hamada R, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2020; (62(8)):937-943 doi:10.1111/ped.14224.

    PMID: 32153091
  12. 12

    Percutaneous transluminal renal artery stenting using digital subtraction angiography with diluted contrast medium in a patient with severe chronic kidney disease.

    Oyama Y, Koiwa S, Maruyama T, et al.

    Journal of cardiology cases 2022; (26(5)):317-320 doi:10.1016/j.jccase.2022.06.002.

    PMID: 36312781
  13. 13

    Computed tomography angiography for renal artery stenosis in children: a flip flop isn't always bad.

    Donaldson JS

    Pediatric radiology 2021; (51(3)):383-384 doi:10.1007/s00247-020-04873-0.

    PMID: 33068130

This page provides educational information about diagnostic tests for renovascular hypertension. Always consult your nephrologist or primary care provider to determine which imaging techniques are safest for your specific kidney health.

Get notified when new evidence is published on benign renovascular hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.